A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded an increase of 44.73%. However, over the last six months, the performance has been stronger by -1.85%. The price of ORIC increased 42.61% over the last 30 days. And in the last five days, it has surged by 16.80%.
ORIC Pharmaceuticals Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $16.65 on 03/06/24, and the lowest price during the same period was recorded at $6.33 on 06/27/24.
52-week price history of ORIC Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. ORIC Pharmaceuticals Inc’s current trading price is -29.85% away from its 52-week high, while its distance from the 52-week low is 84.52%. The stock’s price range over this timeframe has been between $6.33 and $16.65. The shares of the Healthcare sector company recorded a trading volume of approximately 1.06 million for the day, which was comparatively higher than the average daily volume of 0.48 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
ORIC Pharmaceuticals Inc (ORIC) has experienced a quarterly rise of 38.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 824.22M and boasts a workforce of 100 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.43, with a change in price of +1.61. Similarly, ORIC Pharmaceuticals Inc recorded 470,681 in trading volume during the last 100 days, posting a change of +15.99%.
ORIC’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ORIC stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
ORIC Stock Stochastic Average
The raw stochastic average for ORIC Pharmaceuticals Inc over the last 50 days is presently at 98.61%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 98.45%. Further, the company’s Stochastic %K and %D values for the last 20 days were 87.93% and 80.05%, respectively.
